INNOVATIONS IN THE DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES MELLITUS
- Authors: Shestakova M.1, Vikulova O.1
-
Affiliations:
- Endocrinology Research Center
- Issue: Vol 23, No 8 (2012)
- Pages: 2-6
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115409
- ID: 115409
Cite item
Open Access
Access granted
Abstract
The paper gives survey data pertinent to the epidemiology of type 2 diabetes mellitus (T2DM), its diagnosis and treatment. It discusses the new diagnostic criterion glycated hemoglobin (HbA1c). Individual target HbA1c values are estimated for different categories of patients. Current drug therapy for T2DM, including the use of innovative agents from the group of incretins, such as dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists, is considered in detail.
Full Text
About the authors
M. Shestakova
Endocrinology Research Center
Email: nephro@endocrincentr.ru
Professor, MD, Correspondent Member of the Russian Academy of Medical Sciences Moscow
O. Vikulova
Endocrinology Research CenterCandidate of Medical Sciences Moscow
References
Supplementary files
